logo
Kalyanaraman becomes latest to leave Maryland Department of Health

Kalyanaraman becomes latest to leave Maryland Department of Health

Yahoo03-06-2025
Dr. Nilesh Kalyanaraman testified in March on nursing home inspections to the House Health and Government Operations Committee. (Photo by Danielle J. Brown/Maryland Matters)
The deputy secretary of public health services is leaving the Maryland Department of Health this week after two years serving under the Moore Administration and more than a decade in both private and public health services in Maryland, state officials confirmed Monday.
Tuesday will be Dr. Nilesh Kalyanaraman's last day with the department.
'We thank Dr. Kalyanaraman for raising his hand to serve the people of Maryland — especially through the COVID pandemic — as a dedicated champion for public health,' according to a spokesperson for Gov. Wes Moore.
His departure is the latest in a string that began in February, when then-Secretary Laura Herrera Scott left amid several controversies at the department, including oversight issues at Clifton T. Perkins Hospital Center, a high-security hospital that has been riddled with complaints of patient abuse and violence.
Secretary Meena Seshamani, a former top official with the U.S. Centers for Medicare and Medicaid Services, took the reins of the department in April.
Just last week, Erin McCullen left her position as the department's chief of staff, a position she's held since 2023. McCullen also worked in the department in various positions from 2013 through 2017. Chase Cook also left his job last week as the department's director of communications, following several years in the position.
Former CMS administrator takes helm of controversy-laden health department
As the deputy secretary of public health services, Kalyanaraman has spoken on a wide variety of health and safety issues throughout the years — from heat illnesses and dental health workforce to bird flu threat levels and more.
Before working with the Moore administration, Kalyanaraman served as the health officer for Anne Arundel County from September 2019 through March 2023, leading the county through the COVID-19 pandemic.
'He was a really, really good resource for the issues that we dealt with during COVID,' said Sen. Pam Beidle (D-Anne Arundel), chair of the Senate Finance Committee. 'He was always willing to do a webinar with us and our constituents. I think he did a really good job guiding our county through COVID.'
Before his time in local government, Kalyanaraman served from 2012 to 2019 as the chief health officer for Baltimore-based Health Care for the Homeless, a nonprofit that provides health care and housing support to 10,000 people in the region annually.
He leaves a health department that's trying to pull itself out of a series of controversies and challenges. During the 2025 legislative session, lawmakers grilled Kalyanaraman for answers about one of those controversies — a significant backlog of nursing home annual inspections.
Kalyanaraman argued that the department had been making progress on the backlog of state inspections, but lawmakers remain concerned that some facilities had not received annual inspections for over four years, putting vulnerable senior citizens at risk of inadequate care.
Kalyanaraman declined Monday to comment on his departure.
Neither McCullen nor Cook responded to a request for comment. But McCullen said in a social media post about her departure from the health department that she was 'filled with immense gratitude for the privilege of serving alongside such dedicated public servants.'
'The experience has been invaluable, and I am forever thankful for the opportunity to contribute to the health and well-being of Marylanders alongside some of the best people you will ever meet,' she said.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump Says Only U.S. Votes by Mail. Here Are the Facts
Trump Says Only U.S. Votes by Mail. Here Are the Facts

Time​ Magazine

time14 minutes ago

  • Time​ Magazine

Trump Says Only U.S. Votes by Mail. Here Are the Facts

President Donald Trump said he will "get rid of" mail-in ballots and voting machines before the 2026 midterm elections—and he's spreading misinformation on social media about the voting methods ahead of time. 'I am going to lead a movement to get rid of MAIL-IN BALLOTS, and also, while we're at it, Highly 'Inaccurate,' Very Expensive, and Seriously Controversial VOTING MACHINES,' Trump posted on Truth Social Monday morning, adding that he will sign an Executive Order eliminating them before the 2026 election. 'We are now the only Country in the World that uses Mail-In Voting. All others gave it up because of the MASSIVE VOTER FRAUD ENCOUNTERED.' Trump reiterated those claims during an Oval Office meeting with Ukrainian President Volodymyr Zelensky in the White House on Monday, once again dubbing it 'corrupt' to reporters. Absentee voting and vote-by-mail allow people to send in their ballots via the postal service. Not all states allow it, and the laws vary in each state that does. Some states permit universal mail-in voting, for example, where anyone can vote by mail for any reason. Others allow it in specific circumstances. Lots of other countries vote by mail Despite what Trump claims, the United States is not the only country that utilizes mail-in ballots. In fact, multiple other countries do, including Canada, the United Kingdom, Australia, and Germany. The International Institute for Democracy & Electoral Assistance (IDEA), an intergovernmental organization that works to protect democratic institutions, found that 34 countries allow postal voting—12 of which allow it for all voters, and 22 of which allow it for some voters. IDEA found that the COVID-19 pandemic created an incentive for these countries to upscale their mail-in ballot infrastructure for public health reasons, but most have kept these avenues open for citizens. Although Trump says he will use Executive Order powers to end the practice, the U.S. Constitution directs state legislatures to determine the "times, places and manner" of holding elections, which is part of the reason why only some states have vote-by-mail practices, and each state with vote-by-mail has different requirements. There's no evidence that mail voting is corrupt Trump's post continued by reviving well-worn rhetoric—that mail-in voting is used by his opponents, Democrats, for corrupt purposes, despite no evidence to support this claim. 'Democrats are virtually Unelectable without using this completely disproven Mail-In SCAM. ELECTIONS CAN NEVER BE HONEST WITH MAIL IN BALLOTS/VOTING, and everybody, IN PARTICULAR THE DEMOCRATS, KNOWS THIS,' Trump said. 'I, AND THE REPUBLICAN PARTY, WILL FIGHT LIKE HELL TO BRING HONESTY AND INTEGRITY BACK TO OUR ELECTIONS.' This is not the first time Trump has attacked mail-in ballots as a form of voting. During the 2020 election—which Trump lost to former President Joe Biden—Trump heavily attacked the use of mail-in ballots and suggested, without evidence, that mail voting would lead to 'massive fraud, and abuse,' and discredited physical ballot drop boxes. He also threatened to deploy law enforcement to polling places on Election Day. Trump's rhetoric made it seem that mail-in ballots were a Democratic plot and the election would be 'rigged' as a result. When he lost the 2020 election, Trump was quick to blame mail-in ballots, drop boxes, and voting machines, claiming that the system was corrupt. Though research shows that partisan rhetoric made voting by mail a more 'Democrat' thing to do in 2020 and 2022, experts—including the Brennan Center for Justice, the Bipartisan Policy Center, and the Center for Election Innovation and Research—have debunked Trump's claims and found that vote-by-mail methods only expand voting options for voters, and that the 2020 election was not marred by corruption. In the 2024 election, the U.S. Election Assistance Commission found that though mail-in ballots were not quite as popular as during the COVID-19 pandemic, they still accounted for nearly a third of ballots cast. And, in part motivated by Trump's claims of fraud, at least 19 states have passed new mail voting restrictions in place to make the practice more difficult since 2020, according to the Brennan Center for Justice.

Wall Street sees new obesity pills as priced near Wegovy and Zepbound
Wall Street sees new obesity pills as priced near Wegovy and Zepbound

Yahoo

time16 minutes ago

  • Yahoo

Wall Street sees new obesity pills as priced near Wegovy and Zepbound

By Maggie Fick and Bhanvi Satija SEATTLE (Reuters) -U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with their weight-loss injections, analysts and investors say, in a departure from the usual practice of charging more for new medicines despite pressure to cut prices. Neither drugmaker has disclosed pricing plans for their new daily oral medications. With regulatory approvals and launches still months away, pricing plans could change. Denmark-based Novo expects approval later this year and to launch soon after, while Indianapolis-based Lilly expects to launch by August 2026. Novo's Wegovy and Lilly's Zepbound, administered as weekly injections, are the only highly effective weight-loss drugs targeting the GLP-1 hormone, and the United States is their biggest market. U.S. list prices are about $1,000 per month or more, with both companies offering a monthly supply for $499 to customers paying cash rather than using health insurance. Both companies have said they developed oral weight-loss drugs to meet patient needs and widen access to the market, mindful that some people are averse to injections. The pills, however, are not more effective than the injections. Lilly said this month its pill orforglipron cut weight by 12.4% after 72 weeks in a trial. That compares with weight loss of 15% for Novo's daily oral semaglutide. Both trail Lilly's injection at up to 21%. UBS analyst Trung Huynh said that will cap Lilly's pricing. The price is "probably going to come on par with the current drugs today or slightly lower," Huynh said. TD Cowen analyst Michael Nedelcovych said he expects Novo's pill to debut near Wegovy's price, citing the precedent of its diabetes pill Rybelsus being priced at parity with injection Ozempic, the diabetes-treatment version of Wegovy. Novo executives told analysts this month they were not in a hurry for discount pricing for the new pill. Oral GLP-1 drugs will fill a niche rather than displace injections, according to analysts. TD Cowen estimates that pills will account for a percentage share of the global obesity drug market in the mid-teens by 2030, which could reach $150 billion by then. GROWING CASH PAY U.S. doctors, patients and insurers are pressing for lower prices to make the weight-loss drugs more affordable for the 40% of Americans who are obese. Typically, drugmakers launch new drugs at higher prices, citing scientific advances. President Donald Trump and lawmakers from both parties have urged the companies to reduce U.S. prices. Novo declined to comment on pricing, pointing to August 6 comments by David Moore, its U.S. operations head, saying that the company may tap customers paying cash directly via its new NovoCare pharmacy, which was launched this year to sell Wegovy outside of insurance. A Lilly spokesperson called it premature to comment on pricing and launch plans for its pill because the company has not yet submitted data for regulatory approval. Peak annual sales forecasts for Lilly's orforglipron fell to as low as $10 billion after its trial data from earlier estimates of up to $30 billion, according to a Reuters review of analyst estimates. HSBC forecasts $15 billion in peak annual sales for Novo's pill, while Barclays expects only $1 billion. MANUFACTURING VOLUME A key question is how much supply will be available at the time of launch. Shortages of injectable GLP-1s in 2023 and 2024 opened the U.S. market to cheaper compounded versions as the manufacturers failed to anticipate the huge demand. "It's all about scale and pricing," said Kevin Gade, portfolio manager at Bahl & Gaynor, which owns Lilly shares. Gade pointed to Novo's manufacturing challenge. A weekly regimen of the pill requires about 75 times more active ingredient than the highest-dose weekly Wegovy injection, two analysts told Reuters. Lilly has said it already has $808.5 million in orforglipron inventory for next year's expected launch. Novo has said it will launch its pill without supply constraints after billions of dollars in investment to expand semaglutide production. Despite the high production needs, Novo is unlikely to debut its pill at a higher price than Wegovy, said Karen Andersen, healthcare strategist at Morningstar. "Particularly in the growing cash-pay market, I doubt it can risk a launch at a premium to Wegovy," Andersen added.

Trump on what it will take to bring Israeli hostages home: Hamas must be 'confronted and destroyed'
Trump on what it will take to bring Israeli hostages home: Hamas must be 'confronted and destroyed'

Fox News

time27 minutes ago

  • Fox News

Trump on what it will take to bring Israeli hostages home: Hamas must be 'confronted and destroyed'

President Donald Trump said Monday that the remaining Israeli hostages will only be returned once Hamas is "confronted and destroyed," as the Gaza-based terrorist group cited alleged progress in ongoing ceasefire talks. The U.S. and Israel pulled their negotiators from Qatar last month, with Trump's special envoy Steve Witkoff saying at the time that Hamas demonstrated a "lack of desire to reach a ceasefire in Gaza" and were likely not negotiating in good faith. "We will only see the return of the remaining hostages when Hamas is confronted and destroyed!!!" Trump wrote on TRUTH Social on Monday morning. "The sooner this takes place, the better the chances of success will be," Trump wrote. "Remember, I was the one who negotiated and got hundreds of hostages freed and released into Israel (and America!). I was the one who ended 6 wars, in just 6 months. I was the one who OBLITERATED Iran's Nuclear facilities. Play to WIN, or don't play at all! Thank you for your attention to this matter!" The message came ahead of Trump's meeting with Ukrainian President Volodymyr Zelenskyy and European leaders at the White House on Monday as they try to iron out a separate peace deal with Russia. Meanwhile, in the Middle East, the Iran-backed Hamas said Monday it has accepted a new proposal from Arab mediators for a ceasefire in the Gaza Strip that would still need Israel's approval. Israeli Prime Minister Benjamin Netanyahu said in response that Hamas is under "enormous pressure" after Israel announced plans to reoccupy Gaza City and other heavily populated areas after ceasefire negotiations again stalled in Qatar last month. "I hear the media reports – and from them, you can draw one conclusion: Hamas is under enormous pressure," Netanyahu said in a Hebrew video statement translated by Fox News. Netanyahu also said on Monday he visited the Gaza Division, where he met with the senior Israeli Defense Forces command staff, and expressed "tremendous appreciation for the great achievements of the IDF in the War of Rebirth – the war on seven fronts." The prime minister said he was "deeply impressed by the fighting spirit and determination to complete the defeat of Hamas and to bring about the release of all our hostages." He said he also spoke to the defense minister and chief of staff "about our plans regarding Gaza City and the completion of our missions." A diplomat briefed on the negotiations with Hamas told Fox News that "through pressure on Hamas to accept, Qatari and Egyptian mediators secured a breakthrough that preserves 98% of the Witkoff proposal, which the Israeli side had previously agreed to." "The mediators were able to secure this outcome despite recent events and developments moving toward further escalation," the diplomat said. "This step marks the beginning of the road to a comprehensive solution." Egyptian Foreign Minister Badr Abdelatty said mediators are "exerting extensive efforts" to revive a U.S. proposal for a 60-day ceasefire, during which some hostages would be released and the sides would negotiate a lasting ceasefire and the return of the rest. He spoke during a visit to Egypt's Rafah crossing with Gaza, which has not functioned since Israel seized the Palestinian side in May 2024. He was accompanied by Mohammad Mustafa, the prime minister of the Palestinian Authority. Abdelatty said Qatari Prime Minister Sheikh Mohammed bin Abdulrahman Al Thani had joined the talks, which include senior Hamas leader Khalil al-Hayya, who arrived in Cairo last week. He said they are open to other ideas, including a comprehensive deal that would release all the hostages at once. Bassem Naim, a senior Hamas official, later told the Associated Press that the terrorist group had accepted the proposal introduced by the mediators, without elaborating. An Egyptian official, speaking to the AP on condition of anonymity to discuss the sensitive talks, said the proposal includes changes to Israel's pullback of its forces and guarantees for negotiations on a lasting ceasefire during the initial truce. The official said it is almost identical to an earlier proposal accepted by Israel, which has not yet joined the latest talks. Netanyahu has vowed to continue the war until all the hostages are returned and Hamas has been disarmed, and to maintain lasting security control over Gaza. Hamas has said it will only release the remaining hostages in exchange for a lasting ceasefire and an Israeli withdrawal.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store